1. Luo JC*, Huang KW, Leu HB, et al. Randomised clinical trial: rabeprazole plus aspirin is not inferior to rabeprazole plus clopidogrel for the healing of aspirin-related peptic ulcer. Aliment Pharmacol Ther 2011;34:519-25.

2. Luo JC*, Leu HB, Huang KW, et al. Incidence of bleeding from gastroduodenal ulcers in patients with end-stage renal disease receiving hemodialysis. CMAJ 2011;183:E1345-51. 

3. Luo JC*, Huo TI, Hou MC, et al. Clopidogrel delays gastric ulcer healing in rats. Eur J Pharmacol 2012;695:112-9. 

4. Lin CC, Hu HY, Luo JC*, et al. Risk factors of gastrointestinal bleeding in clopidogrel users: a nationwide population-based study. Aliment Pharmacol Ther 2013;38:1119-28.  

5. Tseng CL, Chen YT, Huang CJ, Luo JC*, et al. Short-term use of glucocorticoids and risk of peptic ulcer bleeding: a nationwide population-based case-crossover study. Aliment Pharmacol Ther 2015;42:599-606.

6. Luo PJ, Lin XH, Lin CH, Luo JC*, et al. Risk factors for upper gastrointestinal bleeding among aspirin users: an old issue with new findings from a population-based cohort study. J Form Med Assoc 2019;118:939-944.

7. Lin XH, Huang KH, Chuang WH, Luo JC*, et al. The long term effect of metabolic profile and microbiota status in gastric cancer patients after subtotal gastrectomy. PLoS One 2018 Nov. 5;13(11):e0206930.

8. Lin XH, Jiang JK, Luo JC*, et al. The long term microbiota and metabolic status in patients with colorectal cancer after curative colon surgery. PLoS One 2019 Jun 14;14(6): e0218436.

9. Chang TE, Luo JC^*, Yang UC, et al. Fecal microbiota profile in patients with inflammatory bowel disease in Taiwan. J Chin Med Assoc 2021;84: 580-587.